The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis

BACKGROUND: Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes of IVF have been conflicting. The aim of the study was to compare IVF-ET outcomes among women with poor ovarian...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xue-Li, Wang, Li, Lv, Fang, Huang, Xia-Man, Wang, Li-Ping, Pan, Yu, Zhang, Xiao-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371493/
https://www.ncbi.nlm.nih.gov/pubmed/28328856
http://dx.doi.org/10.1097/MD.0000000000006443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371493/
https://www.ncbi.nlm.nih.gov/pubmed/28328856
http://dx.doi.org/10.1097/MD.0000000000006443

Ejemplares similares